For children with atopic dermatitis (AD) and their parents, there were no additional benefits of shared medical appointments (SMA) in parental emotional coping, anxiety about corticosteroids, quality of life (QOL), and disease activity. New patients with AD aged <18 years and their parents assigned to the SMA group or the individual appointments (IA) group. Before the intervention, 2 months and 6 months thereafter, researchers assessed parental emotional coping, QOL, anxiety about corticosteroids, and patient disease activity. Among the findings:

• Of 140 patients enrolled, 69 were assigned to the SMA and 71 to the IA intervention of whom 114 completed the intervention.
• After 2 months, there were no differences between SMAs and IAs in effects on emotional coping, QOL, anxiety about corticosteroids, and disease activity.
• From initial appointment to long-term follow-up, both groups showed substantial improvements, but no significant in disease activity and significant reduction in anxiety about corticosteroids.